The present invention provides isolated peptides or the fragments derived fromSEQ ID NO: 45, which bind to anHLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may includethe above mentioned amino acid sequencewith substitution deletion, or addition of one, two, or several amino acidssequences. The invention also provides pharmaceuticalcompositions including these peptides. The peptides of this invention can beused for diagnosing or treating cancer.